Showing 8101-8110 of 23088 results for "".
Developing Trends in Medical Practice Revenue and Operating Expenses
https://reachmd.com/programs/clinicians-roundtable/developing-trends-in-medical-practice-revenue-and-operating-expenses/3866/Each year the Medical Group Management Association produces a report on practice operating costs and profitability. Dr. Larry Kaskel discusses the most recent results with Dr. William Jessee, president of Medical Group Management Association. The critical finding is that practice-operating costs areClinical Trials to Cure Type 1 Diabetes With Generic Drugs
https://reachmd.com/programs/focus-on-diabetes/clinical-trials-to-cure-type-1-diabetes-with-generic-drugs/3853/The first clinical trial using generic drugs to cure type 1 diabetes has created quite a buzz in the diabetic patient and physician communities. Join host Dr.Bruce Bloom and his guest, Dr. Denise L. Faustman, associate professor of medicine at Harvard Medical School and director of the ImmunobiologyThe Rise and Risks of Methadone Prescriptions
https://reachmd.com/programs/clinicians-roundtable/the-rise-and-risks-of-methadone-prescriptions/3820/A drug that first gained prominence as a treatment for heroin addiction, methadone is now more commonly prescribed by medical practitioners for a range of severe pains. Why are we seeing this rise in methadone use? Are we, as prescribers, doing everything we can to understand the pharmacokinetics anBarriers to Independent Nurse Practitioner Ownership
https://reachmd.com/programs/clinicians-roundtable/barriers-to-independent-nurse-practitioner-ownership/3768/Carolyn Zaumeyer, a nurse practitioner, discusses with host Lisa D'Andrea the key barriers for a nurse practitioner to establish an independent practice. The nurse practitioner must ensure the practice structure and operations are in compliance with the applicable laws. Ms. Zaumeyer also highlight2,000 Years to End Female Genital Cutting
https://reachmd.com/programs/focus-on-global-medicine/2000-years-to-end-female-genital-cutting/3725/Molly Melching, founder of Tostan, an NGO organization based in Senegal, West Africa, that uses human rights education to empower communities around healthcare issues, joins host Dr. Maurice Pickard. They explore Tostan's successful education campaign on the health and human rights effects of femaleMDR and XDR-TB: Progress on Many Fronts
https://reachmd.com/programs/focus-on-global-medicine/mdr-and-xdr-tb-progress-on-many-fronts/3723/More than half a million people around the world are stricken with multi- or extensively drug-resistant tuberculosis every year, but only a fraction of these patients receive effective treatment for their disease. In a few TB hotspots in South America and Asia, we are seeing years of research investUsing Mouse Models to Understand Metastatic Cancer
https://reachmd.com/programs/clinicians-roundtable/using-mouse-models-to-understand-metastatic-cancer/3698/We almost always cure mice of cancer, but the same treatment often fails in humans. Is the problem the mouse model? Join host Dr. Bruce Bloom, and his guest, Dr. Thomas Seyfried, professor of biology at Boston College and associate editor of the Journal of Nutrition and Metabolism, as they reviewProprietary Data: Should Researchers Share?
https://reachmd.com/programs/focus-on-public-health-policy/proprietary-data-should-researchers-share/3651/Cancer researchers used to work in silos and would not share information until it was accepted for publication. Multi-disciplinary, intra-institution and inter-institution research teams are challenging the status quo. Is this a good thing, and what are the challenges? Join host Dr. Bruce Bloom as hPsychoactive Drug Research: What's New with Hallucinogens?
https://reachmd.com/programs/clinicians-roundtable/psychoactive-drug-research-whats-new-with-hallucinogens/3634/It used to be common for researchers to study the potential medicinal uses for hallucinogenic drugs, including psilocybin, ecstasy, and LSD; however, the 60's left a blemish on legitimate research and it grinded to a halt. Host Dr. Leslie Lundt welcomes Dr. Matthew Johnson, a psychopharmacologist inRetail Clinics: Gold Mines or Flops?
https://reachmd.com/programs/clinicians-roundtable/retail-clinics-gold-mines-or-flops/3618/Recent reports tell us that the number of retail health clinics is declining, but according to Tom Charland, chief executive officer of Merchant Medicine, this data incorrectly implies that the retail clinic model is an unsuccessful fad. Mr. Charland clarifies with host Dr. Larry Kaskel what he char